Interactions of allogeneic human mononuclear cells in the two-way mixed leucocyte culture (MLC): Influence of cell numbers, subpopulations and cyclosporin

Clinical and Experimental Immunology

Volumn 115, Issue 2, 1999, Pages 301-308

  Sato, T ^a,b   Deiwick, A ^a,b   Raddatz, G ^a,b   Koyama, K ^a,b   Schlitt, Hans J ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b AKITA UNIVERSITY   (Japan)

Author keywords

Mixed leucocyte culture; Two way MLR

Indexed keywords

CYCLOSPORIN;

ARTICLE; CELL COUNT; CELL CULTURE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; MIXED LEUKOCYTE CULTURE; NATURAL KILLER CELL; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; APOPTOSIS; CYCLOSPORINE; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032895917     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00784.x     Document Type: Article

References (26)

1. 1 Bain B, Vas MR, Lowenstein L. The development of large immature mononuclear cells in mixed leukocyte cultures. Blood 1964; 23:108-16.
2. 2 Bach F, Hirschhorn K. Lymphocyte interaction: a potential histocompatibility test in vitro. Science 1964; 143:813-4.
3. 3 Bach FH, Voynow NK. One-way stimulation in mixed leukocyte cultures. Science 1966; 153:545-7.
4. 4 Schlitt HJ, Raddatz G, Steinhoff G, Wonigeit K, Pichlmayr R. Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation 1993; 56:951-5.
5. 5 Richter N, Raddatz G, Steinhoff G, Schäfers HJ, Schlitt HJ. Transmission of donor lymphocytes in clinical lung transplantation. Transplant Int 1994; 7:414-9.
6. 6 Schlitt HJ, Kanehiro H, Raddatz G et al. Persistence of donor lymphocytes in liver allograft recipients. Transplantation 1993; 56:1001-7.
7. 7 Richter N, Raddatz G, Graeter T, Schäfers HJ, Schlitt HJ. Allogeneic lymphocyte chimerism in lung allograft recipients. Transplant Immunol 1995; 3:74-80.
8. 8 Burdick JF, Vogelsang GB, Smith WJ et al. Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med 1988; 318:689-91.
9. 9 Jamieson NV, Joysey V, Friend PJ et al. Graft-versus-host disease in solid organ transplantation. Transplant Int 1991; 4:67-71.
10. 10 Schlitt HJ, Tischler HJ, Ringe B, Maschek H, Dietrich E, Kuse E, Pichlmayr R, Link H. Allogeneic liver transplantation for venoocclusive disease after bone marrow transplantation - clinical and immunological considerations. Bone Marrow Transplant 1995; 16:473-8.
11. 11 Lawler SD, Ukaejiofo EO, Reeves BR. Interaction of maternal and neonatal cells in mixed-lymphocyte cultures. Lancet 1975; ii:1185-7.
12. + lymphocytes that kill allogeneic and xenogeneic major histocompatibility complex class I targets. Hum Immunol 1995; 44:50-57.
13. 13 Borel JF, Baumann G, Chapman I, Donatsch P, Fahr A, Mueller EA, Vigouret JM. In vivo pharmakological effects of cyclosporin and some analogues. Adv Pharmacol 1996; 35:115-246.
14. 14 Labalette M, Queyrel V, Masy E, Noel C, Pruvot FR, Dessaint JP. Implications of cyclosporine in up-regulation of bel-2 expression and maintenance of CD8 lymphocytosis in cytomegalovirus-infected allograft recipients. Transplantation 1995; 59:1714-23.
15. 15 Heslop BF, McNeilage LJ. Natural cytotoxicity: early killing of allogeneic lymphocytes in rats. Immunol Rev 1979; 73:35-51.
16. 16 Rolstad B, Fossum S, Bazin H, Kimber I, Marshall J, Sparshott SM, Ford WL. The rapid rejection of allogeneic lymphocytes by a non-adaptive, cell-mediated mechanism (NK activity). Immunol 1985; 54:127-38.
17. 17 Rolstad B, Wonigeit K, Vaage JT. Alloreactive rat natural killer (NK) cells in vivo and in vitro: the role for the major histocompatibility complex. In: Rolstad B, ed. Natural immunity to normal hemopoietic cells. Boca Raton: CRC Press, 1994:99-149.
18. 18 Rolstad B, Vaage JT, Naper C, Lambracht D, Wonigeit K, Joly E, Butcher GW. Positive and negative MHC class I recognition by rat NK cells. Immunol Rev 1997; 155:91-104.
19. 19 lyengar AR, Bonham CA, Antonysamy MA et al. Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus. Transplantation 1997; 63: 1193-9.
20. 20 Martin DR, Sheng-Tanner X, Miller RG. Rapid and long-term changes to host cytotoxic T lymphocyte precursors reactive to donor antigens caused by intravenous injection of histoincompatible lymphocytes. Transplantation 1992; 54:125-9.
21. 21 Thomas JM, Verbanac KM, Carver FM, Kasten-Jolly J, Haisch CE, Gross U, Smith PJ. Veto cells in transplantation tolerance. Clin Transplant 1994; 8:195-203.
22. 22 Miller RG. An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature 1980; 287:544-6.
23. + cells. Immunol 1998; 94:101-8.
24. 24 Starzl TE, Demetris AJ, Trucco M et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17:1127-52.
25. 25 Schlitt HJ, Hundrieser J, Ringe B, Pichlmayr R. Donor-type microchimerism associated with rejection eight years after liver transplantation. N Engl J Med 1994; 330:646-7.
26. 26 Schlitt HJ, Hundrieser J, Hisanaga M, Uthoff K, Karck M, Wahlers T, Wonigeit K, Pichlmayr R. Patterns of donor-type microchimerism after heart transplantation. Lancet 1994; 343:1469-71.